Alternatively spliced products CC3 and TC3 have opposing effects on apoptosis

Area of Science:

• Molecular Biology
• Cell Biology
• Oncology

Background:

• The CC3 gene acts as a metastasis suppressor in small cell lung carcinoma (SCLC).
• Tumor cell apoptotic resistance is a key factor in metastasis.
• CC3's mechanism involves impairing this resistance.

Purpose of the Study:

• To investigate an alternatively spliced RNA of CC3, named TC3.
• To characterize the functional and regulatory properties of TC3.
• To understand the opposing roles of CC3 and TC3 in apoptosis.

Main Methods:

• Analysis of alternatively spliced RNA variants (CC3 and TC3).
• Overexpression studies in rodent fibroblasts to assess cell death and survival.
• Investigation of protein degradation pathways, including proteasome interaction.
• Examination of protein domains responsible for apoptotic and anti-apoptotic activities.

Main Results:

• TC3 encodes an unstable protein with anti-apoptotic activity, contrasting CC3's pro-apoptotic function.
• TC3 protects cells from CC3-induced death and other death stimuli.
• The unique carboxyl terminus of TC3 confers anti-apoptotic function and targets it for rapid proteasomal degradation.
• CC3's death-inducing activity involves mitochondrial membrane potential disruption.

Conclusions:

• CC3 and TC3 represent a novel dual regulator of cell death with opposing functions.
• TC3's instability and anti-apoptotic role are mediated by its unique carboxyl terminus and proteasomal degradation.
• Understanding CC3 and TC3 provides new insights into apoptosis regulation and potential therapeutic strategies for SCLC.